The West Yorkshire, UK-based firm says the system runs from one cylinder of mixed gas and there are separate cycles to prepare anaerobic or microaerobic conditions. It takes less than two minutes and about 18p to create an anaerobic environment, and just 15 seconds and less than 3p to achieve microaerobic conditions.
According to the company, laboratories with low sample throughput can justify this system as a compact and cost-effective alternative to a workstation.
Using the Whitley jar gassing system also eliminates chemical waste and reduces condensation so that samples can be handled and read more easily following incubation, the company says.
Optional accessories include adaptor kits for reusing existing anaerobic jars.
Jar gassing system gains a colour touch screen
And an optional printer for traceability, auditing and accreditation
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Measuring tablet film-coating robustness beyond a single setpoint
Read moreMeeting coating setpoints can hide variation between tablets. Linking core attributes, spray, drying and sampling evidence supports reliable scale-up and a defensible operating window
Trending Articles
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Scaling complexity without losing control: how manufacturing processes are adapting to the next generation of medicines (part V)
As therapies grow more complex, manufacturers must build commercial-scale thinking into early development, focus on meaningful monitoring and favour simplicity to keep production predictable
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Scaling complexity without losing control: how manufacturing processes are adapting to the next generation of medicines (part IV)
Real-time monitoring, digital-first platforms and early scalability planning can help manufacturers to maintain quality, flexibility and speed as dosage forms become more sophisticated
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Scaling complexity without losing control: how manufacturing processes are adapting to the next generation of medicines (part III)
Early collaboration, specialist purification and carefully targeted investment help manufacturers to bridge development and commercial production, improving process robustness, efficiency and dependable supply